InvestorsHub Logo
icon url

boomersooner

06/09/08 11:44 AM

#58306 RE: boomersooner #58305

To further note the story, I came away with the belief that the FDA is in no hurry to allow gene manipulation via vaccine or injection due to recent failure in Stage III testing however the topical percutaneous absorption method was positvely highlighted. If cygx can stop tripping over its collective,,,,,,,,,,,,self, maybe Simplivir has a chance.
icon url

truthhurts

06/09/08 11:50 AM

#58307 RE: boomersooner #58305

boomer...I meant the same in that

the corner of the streets I mentioned is a mighty big one...particularly when a company cannot seem to place one foot in front of the other...meaning walk, let alone run.

5 years on and the magical HSV ointment is still waiting that preliminary FDA meeting on the pre-IND filing requirements.